Skip to main content
Molecular Cancer logoLink to Molecular Cancer
. 2024 Oct 1;23:219. doi: 10.1186/s12943-024-02139-z

Editorial Expression of Concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer

Claire Corcoran 1, Sweta Rani 1, Susan Breslin 1, Martina Gogarty 1, Irene M Ghobrial 2, John Crown 3, Lorraine O’Driscoll 1,
PMCID: PMC11443653  PMID: 39354499

Correction: Mol Cancer 13, 71 (2014)

10.1186/1476-4598-13-71

Published: 24 March 2014

After the publication of this article, the publisher was alerted to an apparent panel duplication and frameshift in Fig. 4B migration (ii) SKBR3-LR NC mimic and 4 C invasion (ii) SKBR3-LR NC mimic. Because the issue was detected ten years after publication, the original images for the study are no longer available. The panel has not been replaced. Readers are urged to take caution when interpreting the content and conclusions of this article.

Footnotes

The online version of the original article can be found at 10.1186/1476-4598-13-71.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES